Suppr超能文献

Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).

作者信息

Paolisso Pasquale, Belmonte Marta, Gallinoro Emanuele, Scarsini Roberto, Bergamaschi Luca, Portolan Leonardo, Armillotta Matteo, Esposito Giuseppe, Moscarella Elisabetta, Benfari Giovanni, Montalto Claudio, Shumkova Monika, de Oliveira Elayne Kelen, Angeli Francesco, Orzalkiewicz Mateusz, Fabroni Margherita, Baydaroglu Nurcan, Munafò Andrea Raffaele, D'Atri Daniele Oreste, Casenghi Matteo, Scisciola Lucia, Barbieri Michelangela, Marfella Raffaele, Gragnano Felice, Conte Edoardo, Pellegrini Dario, Ielasi Alfonso, Andreini Daniele, Penicka Martin, Oreglia Jacopo Andrea, Calabrò Paolo, Bartorelli Antonio, Pizzi Carmine, Palmerini Tullio, Vanderheyden Marc, Saia Francesco, Ribichini Flavio, Barbato Emanuele

机构信息

Clinical Cardiology and Cardiovascular Imaging Unit, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.

Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.

出版信息

Cardiovasc Diabetol. 2025 Jan 13;24(1):14. doi: 10.1186/s12933-024-02560-0.

DOI:10.1186/s12933-024-02560-0
PMID:39806470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730831/
Abstract
摘要

相似文献

1
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).更正：患有严重主动脉瓣狭窄和心脏损伤的糖尿病患者在接受经导管主动脉瓣植入术（TAVI）时使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂。
Cardiovasc Diabetol. 2025 Jan 13;24(1):14. doi: 10.1186/s12933-024-02560-0.
2
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).在接受经导管主动脉瓣植入术（TAVI）的伴有严重主动脉瓣狭窄和心脏损伤的糖尿病患者中使用 SGLT2 抑制剂。
Cardiovasc Diabetol. 2024 Nov 21;23(1):420. doi: 10.1186/s12933-024-02504-8.
3
The reversibility of cardiac damage after transcatheter aortic valve implantation and short-term outcomes in a real-world setting.经导管主动脉瓣植入术后心脏损伤的可逆性及真实世界中的短期结局
Eur Heart J Cardiovasc Imaging. 2025 Apr 30;26(5):918-927. doi: 10.1093/ehjci/jeaf045.
4
Cardiac output, cerebral blood flow and cognition in patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation: design and rationale of the CAPITA study.经导管主动脉瓣植入术治疗严重主动脉瓣狭窄患者的心输出量、脑血流量与认知功能：CAPITA研究的设计与原理
Neth Heart J. 2023 Dec;31(12):461-470. doi: 10.1007/s12471-023-01826-8. Epub 2023 Nov 1.
5
Cerebral Blood Flow in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者的脑血流。
J Am Geriatr Soc. 2021 Feb;69(2):494-499. doi: 10.1111/jgs.16882. Epub 2020 Oct 17.
6
Transapical aortic valve implantation in patients with previous cardiac surgery.经心尖主动脉瓣植入术治疗既往心脏手术患者。
Ann Thorac Surg. 2014 Jan;97(1):37-42. doi: 10.1016/j.athoracsur.2013.07.077. Epub 2013 Sep 24.
7
Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.二尖瓣反流对行经导管主动脉瓣植入术的低射血分数、低跨瓣压差重度主动脉瓣狭窄患者临床结局的影响。
Circ Cardiovasc Interv. 2015 Feb;8(2):e001895. doi: 10.1161/CIRCINTERVENTIONS.114.001895.
8
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis.威尔士专科服务采购案例研究：经导管主动脉瓣置换术治疗重度主动脉瓣狭窄
Appl Health Econ Health Policy. 2022 Jul;20(4):487-499. doi: 10.1007/s40258-021-00692-y. Epub 2022 Feb 25.
9
Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis.经股动脉经导管主动脉瓣植入术治疗糖尿病患者：一项倾向评分匹配分析。
Cardiovasc Diabetol. 2022 Nov 16;21(1):246. doi: 10.1186/s12933-022-01654-x.
10
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗重度主动脉瓣狭窄：来自意大利 OBSERVANT 研究中危倾向人群的结果。
Int J Cardiol. 2013 Sep 1;167(5):1945-52. doi: 10.1016/j.ijcard.2012.05.028. Epub 2012 May 26.

引用本文的文献

1
Aortic Stenosis Prevention: Is a New Cardiovascular Disease Paradigm Coming of Age?主动脉瓣狭窄的预防：一种新的心血管疾病范式即将成熟？
J Clin Med. 2025 Jan 29;14(3):903. doi: 10.3390/jcm14030903.

本文引用的文献

1
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI).在接受经导管主动脉瓣植入术（TAVI）的伴有严重主动脉瓣狭窄和心脏损伤的糖尿病患者中使用 SGLT2 抑制剂。
Cardiovasc Diabetol. 2024 Nov 21;23(1):420. doi: 10.1186/s12933-024-02504-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验